As loss of PTEN and TGFBR2 from prostate has been shown to result in castration-resistant cancer with metastases [27], we assume that miR-216a would play a critical role in the modulation of AR signaling and development of endocrine resistance. The gene discussed is PTEN; the disease is cancer.